Is the Occurrence of Gestational Diabetes Mellitus in Pregnancies Higher Following In Vitro Fertilization Treatment? Why? A Retrospective Cohort Study

IF 0.3 Q4 HEALTH CARE SCIENCES & SERVICES

Journal of Basic and Clinical Health Sciences Pub Date : 2022-11-18 DOI:10.30621/jbachs.1084860

N. A. Aypar Akbag, Merlinda Aluş Tokat, S. Fata, Elif ÜNSAL AVDAL, E. Okyay, Ö. Doğan

{"title":"Is the Occurrence of Gestational Diabetes Mellitus in Pregnancies Higher Following In Vitro Fertilization Treatment? Why? A Retrospective Cohort Study","authors":"N. A. Aypar Akbag, Merlinda Aluş Tokat, S. Fata, Elif ÜNSAL AVDAL, E. Okyay, Ö. Doğan","doi":"10.30621/jbachs.1084860","DOIUrl":null,"url":null,"abstract":"Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk. \nMethods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002–2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed. \nResults: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36–40 at conception during the IVF cycle than the age group 31–35 (95% CI = 1.18–17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07–11.23, p= .038). \nConclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.","PeriodicalId":40972,"journal":{"name":"Journal of Basic and Clinical Health Sciences","volume":" ","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2022-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Basic and Clinical Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30621/jbachs.1084860","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: This study aim to determine the occurrence of gestational diabetes mellitus (GDM) in pregnancies after IVF treatment and to evaluate the factors that reduce this risk. Methods: This retrospective cohort study was conducted using the medical records of pregnant women who conceived following IVF at the in-vitro fertilization center between 2002–2019. The data were obtained from medical records and phone interviews. Univariate and multivariate logistic regression analyses were performed. Results: The incidence of GDM was found to be 16.7%. The regression model indicated that the risk of GDM was 4.57 times higher in the age group 36–40 at conception during the IVF cycle than the age group 31–35 (95% CI = 1.18–17.73, p = .028). Furthermore, women who conceived after the second IVF trial had a risk of GDM 3.464 times higher than those that conceived after their first IVF trial (95% CI = 1.07–11.23, p= .038). Conclusion: As age and number of IVF trials increase in infertile women, the risk of GDM increases after IVF treatment.

查看原文本刊更多论文

体外受精治疗后妊娠期糖尿病的发生率是否更高？为什么？回顾性队列研究

目的：本研究旨在确定体外受精治疗后妊娠期糖尿病（GDM）的发生率，并评估降低这种风险的因素。方法：这项回顾性队列研究使用2002年至2019年间在体外受精中心试管婴儿后怀孕的孕妇的医疗记录进行。这些数据来自医疗记录和电话采访。进行单变量和多变量逻辑回归分析。结果：GDM的发生率为16.7%。回归模型表明，在IVF周期中，36–40岁年龄组受孕时发生GDM的风险是31–35岁年龄组的4.57倍（95%CI=1.18–17.73，p=0.028）。此外，第二次试管婴儿试验后怀孕的女性患GDM的风险是第一次试管婴儿实验后怀孕的妇女的3.464倍（95%CI=1.07–11.23，p=0.038）。结论：随着不孕妇女年龄和试管婴儿试验次数的增加，试管婴儿治疗后患GDM风险增加。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Basic and Clinical Health Sciences HEALTH CARE SCIENCES & SERVICES-

自引率

50.00%

发文量